The Patent Finder

Xwpharma Ltd.

44 patents currently held · Updated Nov 20, 2026
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Previously recorded as XW Laboratories Inc. (to 2021)

0
Ending by 2030
Sep 2036
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 2 fees due Jan 4, 2027
  • 2 fees due Mar 5 to 26, 2027 · next Mar 5
  • 1 fee due Apr 29, 2027
    The maintenance fee for Prodrugs of gamma-hydroxybutyric acid, compositions and uses thereof (US 10,457,627) comes due Apr 29, 2027. Unpaid by Oct 29, 2027, it lapses early.
  • 1 fee due Jun 10, 2027
    The maintenance fee for Prodrugs of gamma-hydroxybutyric acid, compositions and uses thereof (US 10,501,401) comes due Jun 10, 2027. Unpaid by Dec 10, 2027, it lapses early.
  • 2 fees due Aug 13 to 20, 2027 · next Aug 13
  • 1 fee due Sep 12, 2027
    The maintenance fee for Modified Release Compositions of a Gamma-Hydroxybutyric Acid Derivative (US 11,925,710) comes due Sep 12, 2027. Unpaid by Mar 13, 2028, it lapses early.
  • 2 fees due Oct 2 to 14, 2027 · next Oct 2
  • 2 fees due Nov 5, 2027

Which patents, and when each one lapses · Pro

Recent changes

  • 2 of the patents on this record were granted since Aug 22, 2026

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 10,457,627Prodrugs of gamma-hydroxybutyric acid, compositions and uses thereof
In force
 · USPTO record
In forceUSPTO record
US 10,501,401Prodrugs of gamma-hydroxybutyric acid, compositions and uses thereof
In force
 · USPTO record
In forceUSPTO record
US 10,640,451Prodrugs of gamma-hydroxybutyric acid, compositions and uses thereof
In force
 · USPTO record
In forceUSPTO record
US 10,774,031Prodrugs of gamma-hydroxybutyric acid, compositions and uses thereof
In force
 · USPTO record
In forceUSPTO record
US 10,941,107Prodrugs of gamma-hydroxybutyric acid, compositions and uses thereof
In force
 · USPTO record
In forceUSPTO record
US 10,640,476Bicyclic heteroaryl derivatives and preparation and uses thereof
In force
 · USPTO record
In forceUSPTO record
US 10,882,832Bicyclic heteroaryl derivatives and preparation and uses thereof
In force
 · USPTO record
In forceUSPTO record
US 11,401,249Bicyclic heteroaryl derivatives and preparation and uses thereof
In force
 · USPTO record
In forceUSPTO record
US 11,639,337Bicyclic Heteroaryl Derivatives and Preparation and Uses Thereof
In force
 · Medium confidence
In forceMedium confidence
US 10,858,394Preparation and uses of reactive oxygen species scavenger derivatives
In force
 · USPTO record
In forceUSPTO record
10 of 44 patents shown.
Pro members see all 44.
Pro members: see all 44 patents

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

4 pending · 4 no status recorded

Showing 1 to 8 of 8, newest filing first. An application has no patent term. A term is computed when and if it grants, and appears on that patent's own page. Where no title is shown, the bulk publication record carries none and this site holds no USPTO file history for that application.

ApplicationTitleFiledStatus
19/288,914Modified Release Compositions of a Gamma-Hydroxybutyric Acid DerivativeAug 1, 2025Pending
19/288,895Aug 1, 2025No status recorded
19/201,650May 7, 2025No status recorded
18/984,567Ketamine Derivatives and Compositions ThereofDec 17, 2024Pending
18/789,932Pharmaceutical Compositions of a Gamma-Hydroxybutyric Acid DerivativeJul 31, 2024Pending
18/789,859Excipient GranulationsJul 31, 2024Pending
17/737,700May 5, 2022No status recorded
17/149,170Jan 14, 2021No status recorded
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited